OK432 (Picibanil) in the Treatment of Lymphatic Malformations

NCT03427619 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
275
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Richard JH Smith